O

Ossianix

8 employees

OSSIANIX is a privately held biotherapeutics company that develops single domain antibodies based on the highly versatile VNAR structure

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Neuroscience
Antibodies
Biopharmaceuticals
Phage Display

Date founded

2012

Funding rounds raised

O

Ossianix raised undisclosed on October 24, 2014

Investors: BioAdvance

O

Ossianix raised undisclosed on May 23, 2013

Investors: BioAdvance

FAQ